Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

RYCFX vs. PBE: which is better?

Bottom line

RYCFX vs PBE: the short answer

RYCFX (Biotechnology Fund) and PBE (Invesco Biotechnology & Genome ETF) are both mutual funds.

But RYCFX is far broader, holding 74 positions to 33 for PBE, so beyond the top names it adds exposure PBE doesn't have.

PBE is cheaper at 0.59% vs 2.38% — a difference of $179 a year per $10,000 invested.

Over five years, PBE returned +3.4% a year vs +3.0% for RYCFX.

Updated Nov 19, 2026

RYCFX vs PBE side by side

RYCFXPBE
TypeMutual fundETF
Fund familyGuggenheimInvesco
CategoryTechnology SectorTechnology Sector
Expense ratio2.38%0.59%
Annual cost per $10k$238$59
10-yr cost on $10k (prospectus)$2,763$738
Max front load0%None
12b-1 fee1%—
1-yr return+28.4%+24.7%
5-yr return (annualized)+3.0%+3.4%
10-yr return (annualized)+4.8%+5.2%
Best quarter+28.0%+25.3%
Worst quarter−22.7%−24.3%
Net assets (fund)$136.8M$281.9M
Number of holdings7433
Portfolio turnover75%103%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearRYCFXPBEDifference
2025+29.4%+24.7%+4.7%
2024−1.7%+1.1%−2.8%
2023+5.0%+3.7%+1.3%
2022−13.9%−10.8%−3.2%
2021+0.8%+1.6%−0.8%
2020+20.9%+25.5%−4.6%
2019+23.8%+18.3%+5.5%
2018−9.9%+0.2%−10.1%
2017+28.4%+22.4%+6.0%
2016−20.3%−23.0%+2.7%

Source: Fund prospectus bar charts

Holdings overlap

10 of RYCFX's top 25 holdings also appear in PBE's top 25.

Shared top holdings
HoldingRYCFXPBE
Amgen Inc5.05%5.22%
Gilead Sciences Inc4.49%4.43%
Vertex Pharmaceuticals Inc4.32%4.99%
Regeneron Pharmaceuticals Inc2.93%5.47%
Alnylam Pharmaceuticals Inc2.36%3.17%
Biogen Inc2.13%4.79%
Illumina Inc1.94%3.51%
United Therapeutics Corp1.72%4.08%
Incyte Corp1.62%3.06%
Neurocrine Biosciences Inc1.52%2.66%

Source: SEC Form N-PORT

RYCFX top 10

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Gilead Sciences Inc — 4.49%
  4. Vertex Pharmaceuticals Inc — 4.32%
  5. Regeneron Pharmaceuticals Inc — 2.93%
  6. Revolution Medicines Inc — 2.48%
  7. Alnylam Pharmaceuticals Inc — 2.36%
  8. Beone Medicines Ltd — 2.17%
  9. Moderna Inc — 2.15%
  10. Biogen Inc — 2.13%

PBE top 10

  1. Invesco Private Prime Fund — 12.89%
  2. Regeneron Pharmaceuticals, Inc. — 5.47%
  3. Amgen Inc. — 5.22%
  4. CareDx, Inc. — 5.04%
  5. Vertex Pharmaceuticals Inc. — 4.99%
  6. Invesco Private Government Fund — 4.97%
  7. Royalty Pharma PLC — 4.94%
  8. Biogen Inc. — 4.79%
  9. Gilead Sciences, Inc. — 4.43%
  10. United Therapeutics Corp. — 4.08%

FAQ

What is the difference between RYCFX and PBE?
RYCFX (Biotechnology Fund) and PBE (Invesco Biotechnology & Genome ETF) are both mutual funds. But RYCFX is far broader, holding 74 positions to 33 for PBE, so beyond the top names it adds exposure PBE doesn't have.
Which is cheaper, RYCFX or PBE?
PBE has the lower expense ratio (0.59%).
Should I own both RYCFX and PBE?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.